Marja Raekallio

Title: Marja Raekallio: Innovator in Sedation and Anesthesia Compositions

Introduction

Marja Raekallio is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of sedation and anesthesia through her innovative compositions. With a total of 2 patents, her work focuses on enhancing the effectiveness of psychoactive drugs.

Latest Patents

Marja's latest patents include compositions comprising substituted benzofuroquinolizine and psychoactive drugs. The first patent relates to compositions for use in sedation and/or anesthesia, where the composition comprises MK-467 and a psychoactive drug selected from opioids, benzodiazepines, NMDA receptor antagonists, and combinations thereof. This composition is administered using parenteral extravascular administration to a subject in need of sedation and/or anesthesia. The second patent involves compositions for facilitating absorption and distribution of α-adrenergic agonists, where the composition comprises a substituted benzofuroquinolizine and an α-adrenoceptor agonist selected from substituted imidazoles and substituted thiazines. This composition is also administered using parenteral extravascular administration to a subject in need of sedation.

Career Highlights

Marja Raekallio is associated with Vetcare Oy, where she continues to develop her innovative ideas. Her work has been instrumental in advancing the field of veterinary medicine, particularly in sedation techniques.

Collaborations

Marja collaborates with notable colleagues, including Outi Vainio and Juhana Honkavaara, who contribute to her research and development efforts.

Conclusion

Marja Raekallio's contributions to the field of sedation and anesthesia through her innovative compositions highlight her role as a leading inventor. Her work continues to impact the veterinary field positively.